Found 6 matching trials
Intravenous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects PHASE1 The study is designed to investigate the safety and tolerability of CM-101 ...
Show More Location
Tel Aviv Sourasky Medical Center
Learn More & Join Trial
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects PHASE1 CM-101 is developed as treatment for medical conditions involving inflammat...
Show More Location
Tel Aviv Sourasky Medical Center
Learn More & Join Trial
CM-101 in NASH Patients - The SPLASH Study PHASE2 This phase 2a study is a multi-center, double-blind randomized, placebo-con...
Show More Location
Soroka Medical Center - site 203
Learn More & Join Trial
CM-101 in PSC Patients -The SPRING Study PHASE2 This study is designed to assess the safety, tolerability and activity of t...
Show More Location
Scripps Clinic Torrey Pines - site P83
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis PHASE2 This study is designed to assess the safety and tolerability of the anti-hu...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects PHASE1 A two-part study for NAFLD subjects with normal liver functions and in gene...
Show More Location
Hadassah University Hospital - Ein Kerem
Learn More & Join Trial